Director Parvinder Thiara Disposes Shares in Tourmaline Bio, Inc. Following Merger

Parvinder Thiara, a director of Tourmaline Bio, Inc., disposed of 83,782 shares of common stock and 36,800 employee stock options on October 28, 2025, following the completion of a merger with Novartis AG. The shares were tendered in exchange for $48.00 per share, as per the Merger Agreement dated September 8, 2025. The stock options were automatically canceled and converted into cash based on the difference between the merger consideration and the exercise price of the options. This transaction was part of the merger process and resulted in Thiara no longer holding any shares or options in the company.